Scientists find new way to trigger immune cells to fight cancer

Researchers identified a metabolic pathway that can reprogram immune cells to better attack tumors. The discovery could lead to new cancer treatments that work alongside existing immunotherapies, potentially offering patients another option when standard approaches fail or resistance develops.

Originaltitel: Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses